Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Current Liabilities (2021 - 2025)

PAVmed has reported Total Current Liabilities over the past 5 years, most recently at $14.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $14.8 million for Q4 2025, down 58.14% from a year ago — trailing twelve months through Dec 2025 was $14.8 million (down 58.14% YoY), and the annual figure for FY2025 was $14.8 million, down 58.14%.
  • Total Current Liabilities for Q4 2025 was $14.8 million at PAVmed, up from $10.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for PAVM hit a ceiling of $55.0 million in Q1 2024 and a floor of $7.6 million in Q4 2021.
  • Median Total Current Liabilities over the past 5 years was $38.9 million (2022), compared with a mean of $33.0 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 445.12% in 2022 and later plummeted 82.22% in 2025.
  • PAVmed's Total Current Liabilities stood at $7.6 million in 2021, then skyrocketed by 445.12% to $41.2 million in 2022, then soared by 31.5% to $54.2 million in 2023, then crashed by 34.57% to $35.4 million in 2024, then tumbled by 58.14% to $14.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $14.8 million (Q4 2025), $10.5 million (Q3 2025), and $10.5 million (Q2 2025) per Business Quant data.